EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group 2012
October 31 - November 1, 2012
Activities report of the former Genito-Urinary Tract Cancer Group
Non-muscle invasive bladder carcinoma
The long term results of the EORTC 30911 trial comparing intravesical BCG to intravesical epirubicin have been published and concluded that BCG is superior for both overall and disease specific survival.
The final analysis of randomized phase II trial 30993 assessing BCG and sequential MMC/BCG found similar complete response rates in the two treatment groups.
Non-muscle invasive bladder carcinoma
The long term results of the EORTC 30911 trial comparing intravesical BCG to intravesical epirubicin have been published and concluded that BCG is superior for both overall and disease specific survival.
The final analysis of randomized phase II trial 30993 assessing BCG and sequential MMC/BCG found similar complete response rates in the two treatment groups.
Venue
Sorry, this event is quite new so we couldn't find any venue information.
Please check again in the near future.
Please check again in the near future.
Related events
EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group October 31 - November 1, 2012
EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group October 20 - 22, 2011
EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group 15 October, 2010
EORTC Group Meeting: EORTC Genito-Urinary Tract Cancer Group October 15 - 17, 2009
